title: Suramin inhibits renal fibrosis in chronic kidney disease.
abstract: The activation of cytokine and growth factor receptors associates with the development and progression of renal fibrosis. Suramin is a compound that inhibits the interaction of several cytokines and growth factors with their receptors, but whether suramin inhibits the progression of renal fibrosis is unknown. Here, treatment of cultured renal interstitial fibroblasts with suramin inhibited their activation induced by TGF-β1 and serum. In a mouse model of obstructive nephropathy, administration of a single dose of suramin immediately after ureteral obstruction abolished the expression of fibronectin, largely suppressed expression of α-SMA and type I collagen, and reduced the deposition of extracellular matrix proteins. Suramin also decreased the expression of multiple cytokines including TGF-β1 and reduced the interstitial infiltration of leukocytes. Moreover, suramin decreased expression of the type II TGF-β receptor, blocked phosphorylation of the EGF and PDGF receptors, and inactivated several signaling pathways associated with the progression of renal fibrosis. In a rat model of CKD, suramin abrogated proteinuria, limited the decline of renal function, and prevented glomerular and tubulointerstitial damage. Collectively, these findings indicate that suramin is a potent antifibrotic agent that may have therapeutic potential for patients with fibrotic kidney diseases.
authors: Department of Medicine, Rhode Island Hospital and Brown University School of Medicine, Providence, Rhode Island, USA.
authors: Na
authors: N
authors: Liu
authors: Evelyn
authors: E
authors: Tolbert
authors: Maoyin
authors: M
authors: Pang
authors: Murugavel
authors: M
authors: Ponnusamy
authors: Haidong
authors: H
authors: Yan
authors: Shougang
authors: S
authors: Zhuang
references: Mol Cell Biol. 1996 Apr;16(4):1759-69
references: 8657151
references: FASEB J. 2003 Feb;17(2):327-9
references: 12475899
references: Eur J Cancer. 1994;30A(5):678-82
references: 8080687
references: Nat Med. 2005 Aug;11(8):867-74
references: 16041383
references: Kidney Int. 2008 Jul;74(2):196-209
references: 18449171
references: Semin Nephrol. 2007 May;27(3):309-20
references: 17533008
references: J Clin Oncol. 1994 Jan;12(1):166-75
references: 8270974
references: Kidney Int. 1997 May;51(5):1388-96
references: 9150449
references: Cytokine Growth Factor Rev. 2004 Aug;15(4):255-73
references: 15207816
references: Invest New Drugs. 2002 May;20(2):209-19
references: 12099581
references: Cancer Chemother Pharmacol. 2010 Nov;66(6):1019-29
references: 20107799
references: Oncology. 1997 Mar-Apr;54(2):134-40
references: 9075785
references: J Clin Immunol. 2005 Nov;25(6):592-603
references: 16380822
references: Cancer. 2004 Jan 1;100(1):65-71
references: 14692025
references: J Pathol. 2008 Jan;214(2):199-210
references: 18161745
references: Nat Rev Nephrol. 2009 Jun;5(6):319-28
references: 19474827
references: J Urol. 2008 Aug;180(2):461-8
references: 18550128
references: Am J Physiol Renal Physiol. 2009 Oct;297(4):F996-F1005
references: 19640900
references: Kidney Int. 2005 Mar;67(3):931-43
references: 15698432
references: Life Sci. 2000 Sep 1;67(15):1847-57
references: 11043607
references: Kidney Int. 2000 Nov;58(5):2028-43
references: 11044223
references: Am J Kidney Dis. 1994 Feb;23(2):193-8
references: 8311074
references: Oncogene. 2006 Apr 20;25(17):2520-30
references: 16474852
references: J Biol Chem. 2004 Aug 20;279(34):35255-62
references: 15192102
references: Ann Oncol. 1994 Sep;5(7):597-600
references: 7993834
references: Nephrology (Carlton). 2005 Feb;10(1):48-56
references: 15705182
references: Acta Biochim Pol. 2005;52(2):329-37
references: 15990918
references: Kidney Int. 2006 Jan;69(2):213-7
references: 16408108
references: Cancer Lett. 1999 Nov 15;146(2):189-94
references: 10656625
references: Kidney Int. 2006 Nov;70(9):1599-606
references: 16969386
references: Am J Pathol. 1996 Apr;148(4):1169-80
references: 8644858
references: Cancer Res. 1993 May 15;53(10 Suppl):2239-48
references: 8485709
references: Curr Urol Rep. 2005 Mar;6(2):140-5
references: 15717973
references: J Appl Physiol (1985). 2003 Aug;95(2):771-80
references: 12730151
references: Cell Tissue Res. 2000 Jan;299(1):97-103
references: 10654073
references: Am J Pathol. 2009 Oct;175(4):1464-72
references: 19729475
references: Nat Clin Pract Nephrol. 2006 Feb;2(2):101-8
references: 16932401
references: Am J Pathol. 1995 Aug;147(2):362-74
references: 7639330
references: J Surg Res. 2004 Jun 15;119(2):149-59
references: 15145697
references: Pediatr Nephrol. 2000 Dec;15(3-4):290-301
references: 11149129
references: Cancer Res. 2007 Oct 1;67(19):9066-76
references: 17909010
references: J Am Soc Nephrol. 2008 Jan;19(1):12-23
references: 18077793
references: J Clin Invest. 2000 Jul;106(2):225-34
references: 10903338
references: Cancer Treat Rev. 1994 Jul;20(3):259-73
references: 8020006
references: Am J Pathol. 2008 Dec;173(6):1617-27
references: 19008372
references: Anticancer Res. 1995 Mar-Apr;15(2):343-8
references: 7763004
references: Kidney Int. 2007 May;71(9):882-8
references: 17299519
references: Contrib Nephrol. 2003;139:44-65
references: 12854318
references: In Vivo. 2007 Nov-Dec;21(6):957-65
references: 18210741
references: J Clin Oncol. 1989 Apr;7(4):499-508
references: 2926472
references: J Cell Physiol. 1987 Jul;132(1):143-8
references: 3496343
references: Kidney Int. 2010 Aug;78(3):257-68
references: 20520592
references: Nat Rev Nephrol. 2010 Nov;6(11):643-56
references: 20838416
references: J Pharmacol Exp Ther. 2001 Nov;299(2):426-33
references: 11602651